Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Method and apparatus for networked modems
Methods for selective reverse mask planarization and interconnect structures formed thereby
Apparatus and method for masking a clock signal
Communication system including relay station and data frame for the communication system
Servomotor control circuit
Composite high reflectivity layer
UV exposure method for reducing residue in de-taping process
  Randomly Featured Patents
Housing of hand-held type portable telephone
Method for enhancing T cell reactivity toward tumour antigens
Carrier head with a flexure
Liquid crystal display device
Rotational belt exercise apparatus
E-fuse apparatus for controlling reference voltage required for programming/reading e-fuse macro in an integrated circuit via switch device in the same integrated circuit
Cooling water passage structure in cylinder head of internal combustion engine
Transmission brake control assembly
Container for storing and displaying an article
Interactive electronically presented map